Safraz Hamid

BACKGROUND: Despite the advances in the multidisciplinary treatment of gastric adenocarcinoma, the overall 5-year survival remains only 33.3% in North America. R0 resection with adequate lymphadenectomy remains the mainstay therapy…

Background: Metabolic and bariatric surgery (MBS) is a well-established treatment option in the management of obesity and its complications. At times, surgeons may delay MBS if the preoperative hemoglobin A1c (HbA1c) is elevated above a specified cutoff value…

SIMULTANEOUS ROUX-EN-Y GASTRIC BYPASS AND CHOLECYSTECTOMY NATIONWIDE OUTCOMES